# Nicox S.A. (NICXF)

> Healthcare · FR · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NICXF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | € 17.32M | € -4.07M | N/A | € 403.8K | € 4.43M |
| 2024 | € 8.14M | € -23.20M | N/A | € 17.74M | € 3.41M |
| 2023 | € 7.33M | € -22.16M | € 0 | € 25.15M | € 21.41M |
| 2022 | € 3.57M | € -34.16M | € -25.30M | € 25.30M | € 42.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.09 |
| Liabilities / Eq | 0.98 |
| Current Ratio | 3.53 |

## Other views

- [Metrics](https://sponda.capital/en/NICXF.md)
- [Charts](https://sponda.capital/en/NICXF/charts.md)
- [Compare](https://sponda.capital/en/NICXF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.
